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Trichomonas vaginalis in
Pregnancy
Trichomonas vaginalis is a common cause of vaginitis in both the pregnant and
nonpregnant patient. This protozoan is usually susceptible to metronidazole, but
there is reluctance to administer this antibiotic to pregnant patients. The presence
of T. vaginalis usually indicates that the vaginal ecosystem has become unbalanced.
The microflora tends to shift from a lactobacilli-dominant ecosystem to one domi-
nated, most likely, by anaerobes.
This imbalance in the ecosystem may be the factor that is associated with preterm
labor or premature rupture of the membranes. The presence of trichomonads may
not be a significant factor. In addition, the abundance of bacteria provides a food
source for trichomonads, which may present an opportunity of temporary treat-
ment in the first trimester of pregnancy.
Metronidazole remains the only treatment of T. vaginalis vaginitis. The use of
metronidazole gel is not appropriate regardless of the trimester of pregnancy. At
best, the gel would provide temporary relief; however, the gel is not effective in
the treatment of T. vaginalis vaginitis. Moreover, it does not reach significant
tissue or blood levels to treat infection of Bartholin’s glands, Skene’s glands, or
bladder involvement.
In addition to the potential for interruption of the pregnancy, the presence of T.
vaginalis should alert the physician to the possible presence of other sexually
transmitted organisms. T. vaginalis may cause a severe cervicitis, which may result
in vaginal bleeding. Thus, a patient with an abnormal vaginal discharge and a
decrease in hydrogen concentration (pH > 5) should be evaluated for T. vaginalis
as well as bacterial vaginosis.
The treatment of T. vaginalis in pregnancy becomes a worrisome problem.
Although metronidazole has proved to be relatively safe, there is great reluctance to
administer this agent to pregnant women, especially in the first trimester. Anti-
microbial trials are not conducted in pregnant women for obvious reasons. Perhaps
the following approach can be taken in the first trimester of pregnancy. The initial
treatment can be focused on reducing the number of bacteria because they will most
likely consist ofgram-negative facultative anaerobes and gram-negative and gram-
positive obligate anaerobes. If the whiff test is positive, than an agent such as
clindamycin cream can be utilized. If the whiff test is negative, amoxicillin/
clavulanate (Augmentin, Beecham Laboratories, Bristol, TN), 500 mg t.i.d, for
10 days, can be utilized. If there is strong suspicion that either Neisseria gonor-
rhoeae or Chlamydia trachomatis or both are present, Augmentin should be effec-
tive.
Following the completion of treatment, the patient’s vaginal ecosystem should
be re-evaluated. The goal is not the eradication of T. vaginalis but a significant
reduction in associated bacteria. Once the patient enters the second trimester, oral
metronidazole can be administered.
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The obstetrician could use assurance in the treatment of T. vaginalis vaginitis in
pregnancy. Therefore, it would be most helpful to hear from the infectious-disease
specialists regarding their suggestions or recommendations in the treatment of T.
vaginalis vaginitis in pregnancy.
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